If you’re dealing with those stubborn, daily aches and pains, trust me - you are definitely not alone. Lately, we’ve had so many people come to us who are just totally fed up with living in constant discomfort. They're looking for safe, effective alternatives to standard painkillers that actually work.

That’s exactly why I always recommend Palmitoylethanolamide or PEA for short. The feedback we’ve gotten since we started introducing it has been absolutely phenomenal. Honestly, it’s the best feeling in the world to see customers who have struggled with brutal, chronic pain for decades finally getting the real, long-awaited relief they deserve.

So, what exactly is PEA? It’s a natural, fat-soluble molecule found in everyday foods like meat, eggs, and peanuts, but your own body actually manufactures it on demand to fight inflammation right where it hurts. Think of it like your body's built-in volume knob for pain signals. By calming down overactive immune cells in your nervous system, PEA essentially shuts down the source of distress from the inside out.

The catch? When you’ve been dealing with chronic pain for a long time, your body simply can’t produce enough PEA to keep up.

Fortunately, clinical research shows that supplementing with PEA can make a massive difference. For instance, if you suffer from arthritis, a randomised trial of 111 people with knee osteoarthritis found that taking 600 mg of PEA daily slashed pain by up to 49.5% in eight weeks, while also easing stiffness ⁽¹⁾. Another study focused on TMJ (jaw joint) pain showed an incredible 87% reduction in pain within just two weeks - actually outperforming ibuprofen! ⁽²⁾

If nerve pain is your issue, PEA is a total game-changer. In a massive trial of 636 participants suffering from debilitating sciatica, 600 mg of PEA daily for three weeks drastically reduced pain and disability ⁽³⁾. It showed one of the strongest responses ever reported in pain research, meaning almost every one to two patients treated saw a meaningful benefit. This same review highlighted PEA's success with carpal tunnel syndrome, backed by another study where people with diabetes-related carpal tunnel saw major improvements in pain, numbness, tingling, and hand function over 60 days ⁽⁴⁾. To top it off, a 2023 meta-analysis pooling data from 11 clinical trials confirmed that PEA significantly reduces chronic pain whilst maintaining an excellent safety profile with no nasty side effects ⁽⁵⁾.

If you are ready to stop just masking the pain and start targeting it from the inside out, try PEA to help ease that inflammation and get your life back.

For more information about PEA, drop into Go Vita, Your Health Shop at 5 North Street, Batemans Bay. You can also call our team on (02) 4472 9737 or visit us online at www.govitabatemansbay.com.au. And don’t miss our weekly segment on 2EC radio, where Marianne and Go Vita's Nutritionist Sofia chat about health and wellness with Kimmi Saker every Wednesday after 12.30pm.

References

1. Steels, E., Venkatesh, R., Vitetta, G., & Vitetta, L. (2019). A double-blind randomized placebo-controlled study assessing safety, tolerability and efficacy of Palmitoylethanolamide for symptoms of knee osteoarthritis. Inflammopharmacology, 27(3), 475-485. https://doi.org/10.1007/s10787-019-00582-9
2. Marini, I., Bartolucci, M. L., Bortolotti, F., et al. (2012). Palmitoylethanolamide versus a nonsteroidal anti-inflammatory drug in the treatment of temporomandibular joint inflammatory pain. Journal of Orofacial Pain, 26(2), 99-104.
3. Keppel Hesselink, J. M., & Kopsky, D. J. (2015). Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndrome. Journal of Pain Research, 8, 729-734. https://doi.org/10.2147/JPR.S93106
4. Assini, A., Laricchia, D., Pizzo, R., Pandolfini, L., Belletti, M., Colucci, M., et al. (2010). The carpal tunnel syndrome in diabetes: clinical and electrophysiological improvement after treatment with Palmitoylethanolamide. Neurological Sciences.
5. Lang-Illievich K, Klivinyi C, Lasser C, et al. (2023). Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials. Nutrients, 15(6), 1350.